Doron Therapeutics
Chapel Hill
About Doron Therapeutics
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and regenerative capabilities pivotal to the progressive and degenerative disease of osteoarthritis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2024)
- Website: dorontherapeutics.com
Industries & Categories
Biotechnology, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/doron-therapeutics-96446 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.